StoneX Keeps Buy on Marvell, $375 Price Target
- Rating
- Buy
- Unchanged
- Target
- $375
- Unchanged
- Upside
- +121%
- MRVL at $170 today

What the analyst said
StoneX analyst Cody Acree reiterated a Buy rating and $375 price target on Marvell (NASDAQ: MRVL).
“Marvell agreed to acquire Lumentum in an all-stock deal, and Lumentum reported 1Q27 results the same morning.
Lumentum holders receive a fixed 4.5 Marvell shares per share, worth $1,132 and $115B of enterprise value at signing, a 23.9% premium to the October 28 unaffected closes, and would own about 33% of the combined company.
Marvell targets more than $1B of run-rate cost synergies, mainly in cost of goods sold, and year-one EPS accretion, with closing expected in 1H CY28.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
MRVL trades at $170. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $375 target is 25% above the median.
12-month window: day 0 of 365, closes on November 3, 2027.
Track record
This callOpen: MRVL has not reached $375 yet. This 12-month target is scored on October 7, 2027. Same target as this firm’s October 7, 2026 note, so it is scored there.
Firm track recordStoneX: 70% of its 23 targets at least a year old were reached within 12 months (#19 of 26 firms). Accuracy ranking →
StoneX on Marvell
StoneX price targets on Marvell
7 calls from February 3, 2026 to November 3, 2026. The target went from $130 to $375 (+188%). The rating moved from Hold to Buy.
- November 3, 2026 This noteKept the $375 targetBuy$375
- October 7, 2026Target raised from $275 (+36%)Buy$375
- August 28, 2026Kept the $275 targetBuy$275
- August 24, 2026Kept the $275 targetBuy$275
- May 28, 2026Target raised from $130 (+112%)Buy$275
- March 6, 2026Upgraded to Buy, set a $130 targetBuy$130
- February 3, 2026Earliest call shownHoldNo target




